U
Umesh D. Parashar
Researcher at Centers for Disease Control and Prevention
Publications - 632
Citations - 45080
Umesh D. Parashar is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Rotavirus vaccine. The author has an hindex of 99, co-authored 601 publications receiving 40869 citations. Previous affiliations of Umesh D. Parashar include World Health Organization & National Center for Immunization and Respiratory Diseases.
Papers
More filters
Journal ArticleDOI
Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel
TL;DR: RV5 significantly protected against rotavirus-associated ED visits and hospitalizations in a diverse population of vaccine-eligible children living in southern Israel.
Journal ArticleDOI
Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs
Stephanie Donauer,Daniel C. Payne,Kathryn M. Edwards,Peter G. Szilagyi,Richard Hornung,Geoffrey A. Weinberg,James D. Chappell,Caroline B. Hall,Umesh D. Parashar,Mary Allen Staat +9 more
TL;DR: Three doses of RV5 were effective for preventing rotavirus-related hospitalizations and emergency department (ED) visits in each analysis, with VE estimated as 92% in all three analyses.
Journal ArticleDOI
The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem?
TL;DR: The ultimate control of RV diarrheal will likely require both oral and parenteral vaccines, an observation made with other live oral vaccines for polio, cholera and typhoid fever.
Journal ArticleDOI
Diagnostic performance of rectal swab versus bulk stool specimens for the detection of rotavirus and norovirus: implications for outbreak investigations
Wences Arvelo,Aron J. Hall,Alejandra Estevez,Beatriz Lopez,Nicole Gregoricus,Jan Vinjé,Jon R. Gentsch,Umesh D. Parashar,Kim A. Lindblade +8 more
TL;DR: Testing of properly collected fecal specimens using rectal swabs may be a viable alternative to bulk stool for detection of rotavirus and norovirus, particularly during outbreaks where collection of bulk stool may be difficult.
Journal ArticleDOI
Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
Aisleen Bennett,Aisleen Bennett,Louisa Pollock,Khuzwayo C. Jere,Virginia E. Pitzer,Umesh D. Parashar,J.E. Tate,Robert S. Heyderman,Charles Mwansambo,Neil French,Osamu Nakagomi,Miren Iturriza-Gomara,Dean Everett,Nigel A. Cunliffe,Naor Bar-Zeev +14 more
TL;DR: Prevalence of rotavirus in hospitalised children with AGE has declined significantly and the observed overall effect of the vaccine was 9% greater than expected according to vaccine coverage and efficacy estimates.